Stryker Corporation (0R2S.L)
USD 349.25
(1.06%)
USD 349.25
(1.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 3.88 Billion USD | 36.85% |
| 2022 | 2.84 Billion USD | 9.95% |
| 2021 | 2.58 Billion USD | 16.24% |
| 2020 | 2.22 Billion USD | -18.06% |
| 2019 | 2.71 Billion USD | 6.94% |
| 2018 | 2.53 Billion USD | 10.79% |
| 2017 | 2.29 Billion USD | 5.72% |
| 2016 | 2.16 Billion USD | 16.39% |
| 2015 | 1.86 Billion USD | 49.36% |
| 2014 | 1.24 Billion USD | -0.8% |
| 2013 | 1.25 Billion USD | -27.86% |
| 2012 | 1.74 Billion USD | 3.26% |
| 2011 | 1.68 Billion USD | -3.73% |
| 2010 | 1.75 Billion USD | 9.85% |
| 2009 | 1.59 Billion USD | 4.96% |
| 2008 | 1.51 Billion USD | 16.19% |
| 2007 | 1.3 Billion USD | 21.69% |
| 2006 | 1.07 Billion USD | 7.56% |
| 2005 | 998.8 Million USD | 38.65% |
| 2004 | 720.4 Million USD | 5.89% |
| 2003 | 680.3 Million USD | 24.26% |
| 2002 | 547.5 Million USD | 16.0% |
| 2001 | 472 Million USD | 31.84% |
| 2000 | 358 Million USD | 402.36% |
| 1999 | -118.4 Million USD | -162.71% |
| 1998 | 188.8 Million USD | 2.66% |
| 1997 | 183.9 Million USD | 37.03% |
| 1996 | 134.2 Million USD | -14.69% |
| 1995 | 157.3 Million USD | 30.54% |
| 1994 | 120.5 Million USD | 31.12% |
| 1993 | 91.9 Million USD | 24.69% |
| 1992 | 73.7 Million USD | 43.11% |
| 1991 | 51.5 Million USD | 44.26% |
| 1990 | 35.7 Million USD | 12.62% |
| 1989 | 31.7 Million USD | 20.08% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 1.08 Billion USD | -6.3% |
| 2024 Q1 | 976 Million USD | -22.35% |
| 2024 Q2 | 1.15 Billion USD | 18.65% |
| 2023 Q1 | 735 Million USD | -38.13% |
| 2023 FY | 3.88 Billion USD | 36.85% |
| 2023 Q2 | 965 Million USD | 31.29% |
| 2023 Q4 | 1.25 Billion USD | 35.02% |
| 2023 Q3 | 931 Million USD | -3.52% |
| 2022 FY | 2.84 Billion USD | 9.95% |
| 2022 Q1 | 447 Million USD | -45.42% |
| 2022 Q2 | 772 Million USD | 72.71% |
| 2022 Q3 | 808 Million USD | 4.66% |
| 2022 Q4 | 1.18 Billion USD | 47.03% |
| 2021 Q2 | 732 Million USD | 59.48% |
| 2021 Q3 | 574 Million USD | -21.58% |
| 2021 FY | 2.58 Billion USD | 16.24% |
| 2021 Q1 | 459 Million USD | -38.72% |
| 2021 Q4 | 819 Million USD | 42.68% |
| 2020 Q3 | 859 Million USD | 4395.0% |
| 2020 Q1 | 635 Million USD | -32.73% |
| 2020 FY | 2.22 Billion USD | -18.06% |
| 2020 Q2 | -20 Million USD | -103.15% |
| 2020 Q4 | 749 Million USD | -12.81% |
| 2019 Q2 | 613 Million USD | 16.1% |
| 2019 Q1 | 528 Million USD | -24.36% |
| 2019 Q3 | 628 Million USD | 2.45% |
| 2019 FY | 2.71 Billion USD | 6.94% |
| 2019 Q4 | 944 Million USD | 50.32% |
| 2018 FY | 2.53 Billion USD | 10.79% |
| 2018 Q1 | 591 Million USD | -16.99% |
| 2018 Q2 | 672 Million USD | 13.71% |
| 2018 Q3 | 576 Million USD | -14.29% |
| 2018 Q4 | 698 Million USD | 21.18% |
| 2017 Q4 | 712 Million USD | 36.14% |
| 2017 Q3 | 523 Million USD | 4.39% |
| 2017 Q2 | 501 Million USD | -9.57% |
| 2017 Q1 | 554 Million USD | -16.19% |
| 2017 FY | 2.29 Billion USD | 5.72% |
| 2016 Q1 | 519 Million USD | -19.91% |
| 2016 FY | 2.16 Billion USD | 16.39% |
| 2016 Q2 | 500 Million USD | -3.66% |
| 2016 Q4 | 661 Million USD | 36.01% |
| 2016 Q3 | 486 Million USD | -2.8% |
| 2015 Q1 | 406 Million USD | -13.25% |
| 2015 Q2 | 429 Million USD | 5.67% |
| 2015 FY | 1.86 Billion USD | 49.36% |
| 2015 Q3 | 378 Million USD | -11.89% |
| 2015 Q4 | 648 Million USD | 71.43% |
| 2014 FY | 1.24 Billion USD | -0.8% |
| 2014 Q1 | 131 Million USD | -69.53% |
| 2014 Q2 | 307 Million USD | 134.35% |
| 2014 Q3 | 450 Million USD | 46.58% |
| 2014 Q4 | 468 Million USD | 4.0% |
| 2013 Q1 | 386 Million USD | 4.32% |
| 2013 Q2 | 290 Million USD | -24.87% |
| 2013 Q3 | 150 Million USD | -48.28% |
| 2013 Q4 | 430 Million USD | 186.67% |
| 2013 FY | 1.25 Billion USD | -27.86% |
| 2012 FY | 1.74 Billion USD | 3.26% |
| 2012 Q4 | 370 Million USD | -17.78% |
| 2012 Q3 | 450 Million USD | 1.12% |
| 2012 Q2 | 445 Million USD | -6.51% |
| 2012 Q1 | 476 Million USD | 13.88% |
| 2011 FY | 1.68 Billion USD | -3.73% |
| 2011 Q1 | 423.5 Million USD | 9.6% |
| 2011 Q2 | 400.3 Million USD | -5.48% |
| 2011 Q3 | 444 Million USD | 10.92% |
| 2011 Q4 | 418 Million USD | -5.86% |
| 2010 Q3 | 470.5 Million USD | 5.0% |
| 2010 Q1 | 446.4 Million USD | -13.15% |
| 2010 FY | 1.75 Billion USD | 9.85% |
| 2010 Q4 | 386.4 Million USD | -17.87% |
| 2010 Q2 | 448.1 Million USD | 0.38% |
| 2009 Q2 | 389.8 Million USD | 2.8% |
| 2009 FY | 1.59 Billion USD | 4.96% |
| 2009 Q4 | 514 Million USD | 65.06% |
| 2009 Q3 | 311.4 Million USD | -20.11% |
| 2009 Q1 | 379.2 Million USD | 2.4% |
| 2008 Q4 | 370.3 Million USD | 1.7% |
| 2008 Q2 | 400.9 Million USD | 4.48% |
| 2008 FY | 1.51 Billion USD | 16.19% |
| 2008 Q1 | 383.7 Million USD | 5.73% |
| 2008 Q3 | 364.1 Million USD | -9.18% |
| 2007 Q3 | 688.9 Million USD | 118.77% |
| 2007 Q1 | 325.3 Million USD | 6.34% |
| 2007 FY | 1.3 Billion USD | 21.69% |
| 2007 Q2 | 314.9 Million USD | -3.2% |
| 2007 Q4 | 362.9 Million USD | -47.32% |
| 2006 FY | 1.07 Billion USD | 7.56% |
| 2006 Q1 | 222.1 Million USD | -14.11% |
| 2006 Q2 | 291.9 Million USD | 31.43% |
| 2006 Q4 | 305.9 Million USD | 20.24% |
| 2006 Q3 | 254.4 Million USD | -12.85% |
| 2005 Q2 | 261.6 Million USD | 6.26% |
| 2005 Q4 | 258.6 Million USD | 11.27% |
| 2005 Q3 | 232.4 Million USD | -11.16% |
| 2005 Q1 | 246.2 Million USD | 5.76% |
| 2005 FY | 998.8 Million USD | 38.65% |
| 2004 Q1 | 193.2 Million USD | -5.01% |
| 2004 Q2 | 220.1 Million USD | 13.92% |
| 2004 Q3 | 74.3 Million USD | -66.24% |
| 2004 Q4 | 232.8 Million USD | 213.32% |
| 2004 FY | 720.4 Million USD | 5.89% |
| 2003 Q2 | 161.4 Million USD | 3.2% |
| 2003 Q4 | 203.4 Million USD | 27.84% |
| 2003 FY | 680.3 Million USD | 24.26% |
| 2003 Q1 | 156.4 Million USD | 11.24% |
| 2003 Q3 | 159.1 Million USD | -1.43% |
| 2002 Q2 | 138.7 Million USD | 5.72% |
| 2002 Q4 | 140.6 Million USD | 2.63% |
| 2002 Q3 | 137 Million USD | -1.23% |
| 2002 Q1 | 131.2 Million USD | -4.23% |
| 2002 FY | 547.5 Million USD | 16.0% |
| 2001 Q3 | 108 Million USD | -6.09% |
| 2001 Q4 | 137 Million USD | 26.85% |
| 2001 FY | 472 Million USD | 31.84% |
| 2001 Q1 | 95 Million USD | -9.35% |
| 2001 Q2 | 115 Million USD | 21.05% |
| 2000 FY | 358 Million USD | 402.36% |
| 2000 Q1 | 85.9 Million USD | 35.92% |
| 2000 Q2 | 83.6 Million USD | -2.68% |
| 2000 Q4 | 104.8 Million USD | 25.21% |
| 2000 Q3 | 83.7 Million USD | 0.12% |
| 1999 Q1 | -80.7 Million USD | -320.49% |
| 1999 Q3 | -43.4 Million USD | 24.52% |
| 1999 Q4 | 63.2 Million USD | 245.62% |
| 1999 FY | -118.4 Million USD | -162.71% |
| 1999 Q2 | -57.5 Million USD | 28.75% |
| 1998 Q2 | 51 Million USD | -2.49% |
| 1998 Q4 | 36.6 Million USD | -25.46% |
| 1998 FY | 188.8 Million USD | 2.66% |
| 1998 Q1 | 52.3 Million USD | 2.15% |
| 1998 Q3 | 49.1 Million USD | -3.73% |
| 1997 Q3 | 43.4 Million USD | -3.56% |
| 1997 FY | 183.9 Million USD | 37.03% |
| 1997 Q1 | 44.1 Million USD | 130.89% |
| 1997 Q2 | 45 Million USD | 2.04% |
| 1997 Q4 | 51.2 Million USD | 17.97% |
| 1996 Q1 | 39.8 Million USD | -5.24% |
| 1996 Q4 | 19.1 Million USD | -47.96% |
| 1996 Q3 | 36.7 Million USD | -4.92% |
| 1996 Q2 | 38.6 Million USD | -3.02% |
| 1996 FY | 134.2 Million USD | -14.69% |
| 1995 Q1 | 42.1 Million USD | 3.69% |
| 1995 Q2 | 38.7 Million USD | -8.08% |
| 1995 Q4 | 42 Million USD | 21.39% |
| 1995 FY | 157.3 Million USD | 30.54% |
| 1995 Q3 | 34.6 Million USD | -10.59% |
| 1994 Q1 | 25.5 Million USD | -3.77% |
| 1994 Q3 | 29.2 Million USD | 15.42% |
| 1994 Q4 | 40.6 Million USD | 39.04% |
| 1994 FY | 120.5 Million USD | 31.12% |
| 1994 Q2 | 25.3 Million USD | -0.78% |
| 1993 FY | 91.9 Million USD | 24.69% |
| 1993 Q1 | 22.3 Million USD | -2.19% |
| 1993 Q2 | 21.8 Million USD | -2.24% |
| 1993 Q3 | 21.3 Million USD | -2.29% |
| 1993 Q4 | 26.5 Million USD | 24.41% |
| 1992 Q4 | 22.8 Million USD | 36.53% |
| 1992 Q1 | 17.4 Million USD | 8.07% |
| 1992 Q2 | 16.8 Million USD | -3.45% |
| 1992 Q3 | 16.7 Million USD | -0.6% |
| 1992 FY | 73.7 Million USD | 43.11% |
| 1991 Q4 | 16.1 Million USD | 40.0% |
| 1991 Q1 | 12.2 Million USD | 35.56% |
| 1991 Q2 | 11.8 Million USD | -3.28% |
| 1991 Q3 | 11.5 Million USD | -2.54% |
| 1991 FY | 51.5 Million USD | 44.26% |
| 1990 Q1 | 10 Million USD | 26.58% |
| 1990 Q3 | 8 Million USD | -5.88% |
| 1990 Q2 | 8.5 Million USD | -15.0% |
| 1990 FY | 35.7 Million USD | 12.62% |
| 1990 Q4 | 9 Million USD | 12.5% |
| 1989 Q3 | 7.4 Million USD | -5.13% |
| 1989 Q1 | 53.9 Million USD | 151.58% |
| 1989 FY | 31.7 Million USD | 20.08% |
| 1989 Q4 | 7.9 Million USD | 6.76% |
| 1989 Q2 | 7.8 Million USD | -85.53% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 3050.529% |
| Accuray Incorporated | 504 Thousand USD | -771328.571% |
| Align Technology, Inc. | 643.33 Million USD | -504.348% |
| Elevance Health Inc. | 133.96 Billion USD | 97.098% |
| AxoGen, Inc. | -21.46 Million USD | 18215.739% |
| Boston Scientific Corporation | 2.34 Billion USD | -65.941% |
| CVS Health Corporation | 13.74 Billion USD | 71.709% |
| Cardinal Health, Inc. | 1.24 Billion USD | -212.792% |
| Centene Corporation | 2.93 Billion USD | -32.696% |
| DaVita Inc. | 1.6 Billion USD | -142.578% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 59.614% |
| Hologic, Inc. | 970.2 Million USD | -300.742% |
| Humana Inc. | 4.01 Billion USD | 3.115% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | -254.38% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | -435.832% |
| Masimo Corporation | 136.5 Million USD | -2748.352% |
| McKesson Corporation | 3.9 Billion USD | 0.537% |
| Patterson Companies, Inc. | 252.92 Million USD | -1437.221% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | -208.082% |
| ResMed Inc. | 1.31 Billion USD | -194.569% |
| Henry Schein, Inc. | 615 Million USD | -532.195% |
| Teladoc Health, Inc. | -248.55 Million USD | 1664.254% |
| Universal Health Services, Inc. | 1.17 Billion USD | -230.786% |
| Veeva Systems Inc. | 429.33 Million USD | -805.589% |
| Baxter International Inc. | 390 Million USD | -896.923% |
| Becton, Dickinson and Company | 2.11 Billion USD | -84.178% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | -120.059% |
| Danaher Corporation | 5.38 Billion USD | 27.746% |
| Medtronic plc | 5.14 Billion USD | 24.417% |